Indication
Arginase deficiency
Arginase deficiency, also known as hyperargininemia, is a rare autosomal recessive urea cycle disorder caused by pathogenic variants in the *ARG1* gene. Read more about Arginase deficiency
12 drugs 12 manufacturers
Drugs that treat it
Common Arginase deficiency therapies.
AMMONUL (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
AMMONUL (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonArginase deficiency, also known as hyperargininemia, is a rare autosomal recessive urea cycle disorder caused by pathogenic variants in the *ARG1* gene.
Impairment of the arginase 1 enzyme disrupts hepatic nitrogen detoxification, leading to the toxic systemic accumulation of arginine and its metabolites, alongside variable or episodic hyperammonemia.
Unlike other urea cycle disorders that present catastrophically in the neonatal period, arginase deficiency typically manifests in early childhood with progressive neurological impairment.
Defining clinical features include progressive lower-limb spasticity or spastic paraplegia, loss of motor milestones and ambulation, developmental delay, cognitive regression, microcephaly, and seizures.
- nih.gov
Arginase deficiency, also known as hyperargininemia, is a rare autosomal recessive urea cycle disorder caused by pathogenic variants in the *ARG1* gene Impairment of the arginase 1 enzyme disrupts hepatic nitrogen detoxification, leading to the toxic systemic accumulation of arginine and its metabolites, alongside variable or episodic hyperammonemia Unlike other urea cycle disorders that present catastrophically in the neonatal period, arginase deficiency typically manifests in early childhood w...
- epocrates.com
Arginase deficiency, also known as hyperargininemia, is a rare autosomal recessive urea cycle disorder caused by pathogenic variants in the *ARG1* gene
- medlineplus.gov
Impairment of the arginase 1 enzyme disrupts hepatic nitrogen detoxification, leading to the toxic systemic accumulation of arginine and its metabolites, alongside variable or episodic hyperammonemia
- nih.gov
Defining clinical features include progressive lower-limb spasticity or spastic paraplegia, loss of motor milestones and ambulation, developmental delay, cognitive regression, microcephaly, and seizures
- nih.gov
Defining clinical features include progressive lower-limb spasticity or spastic paraplegia, loss of motor milestones and ambulation, developmental delay, cognitive regression, microcephaly, and seizures
- nih.gov
Defining clinical features include progressive lower-limb spasticity or spastic paraplegia, loss of motor milestones and ambulation, developmental delay, cognitive regression, microcephaly, and seizures
Personalize your experience
Follow Arginase deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.